Class information for:
Level 2: TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
232 19686 40.3 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
54 89702 MENOPAUSE//POLYCYSTIC OVARY SYNDROME//ESTROGEN

Classes in level below (level 1)


ID, lev. below Publications Label for level below
1155 2718 AROMATASE INHIBITORS//EXEMESTANE//ANASTROZOLE
3805 1829 ER ICA//IMMUNOCYTOCHEMICAL ASSAY//PROGESTERONE RECEPTORS
5027 1617 TAMOXIFEN//TOREMIFENE//DROLOXIFENE
5786 1507 ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT
7067 1333 AEBS//ANTIESTROGEN BINDING SITES//ANALOG II
7311 1304 AIB1//STEROID HORMONES SECT//RIP140
7396 1292 ESTROGEN RECEPTOR BETA//ER BETA//RECEPTOR BIOL SECT
8107 1218 GPR30//GPER//PELP1
8182 1210 ANTIPROGESTIN//MIFEPRISTONE//ONAPRISTONE
8236 1205 RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX//BAZEDOXIFENE
13067 798 ESTROGENIC RECRUITMENT//AMINOGLUTETHIMIDE//CYCLIC TREATMENT
13071 798 SERAMS//MATH CHEM//ESTROGEN RECEPTOR LIGANDS
13472 771 PROGESTERONE RECEPTOR ISOFORMS//PROGINS//PROGESTERONE RECEPTOR A
16699 575 JIANGDA PATHOL//APOPTOTIC EFFECTS//BETA CX
19468 439 ENDOXIFEN//DESMETHYLTAMOXIFEN//N DESMETHYL TAMOXIFEN
22489 323 ESTROGEN RECEPTOR ALPHA GENE ESR1//ESTROGEN RECEPTOR POLYMORPHISMS//ESTROGEN RECEPTOR 1
22559 321 MEMBRANE PROGESTIN RECEPTOR//PGRMC1//PGRMC2
22948 307 CENTCHROMAN//DL111 IT//ORMELOXIFENE
31545 121 CRLC OSCAR LAMBRET//UKRAINIAN ONCOL RADIOL//6 METHYL 1 3 8 TRICHLORODIBENZOFURAN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 TAMOXIFEN Author keyword 942 42% 9% 1730
2 AROMATASE INHIBITORS Author keyword 580 51% 4% 810
3 ANASTROZOLE Author keyword 301 68% 1% 267
4 EXEMESTANE Author keyword 283 77% 1% 191
5 ESTROGEN RECEPTOR Author keyword 282 22% 6% 1130
6 RALOXIFENE Author keyword 200 42% 2% 372
7 FULVESTRANT Author keyword 178 70% 1% 149
8 ENDOCRINE THERAPY Author keyword 146 43% 1% 261
9 LETROZOLE Author keyword 134 42% 1% 246
10 GPR30 Author keyword 129 69% 1% 109

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 TAMOXIFEN 942 42% 9% 1730 Search TAMOXIFEN Search TAMOXIFEN
2 AROMATASE INHIBITORS 580 51% 4% 810 Search AROMATASE+INHIBITORS Search AROMATASE+INHIBITORS
3 ANASTROZOLE 301 68% 1% 267 Search ANASTROZOLE Search ANASTROZOLE
4 EXEMESTANE 283 77% 1% 191 Search EXEMESTANE Search EXEMESTANE
5 ESTROGEN RECEPTOR 282 22% 6% 1130 Search ESTROGEN+RECEPTOR Search ESTROGEN+RECEPTOR
6 RALOXIFENE 200 42% 2% 372 Search RALOXIFENE Search RALOXIFENE
7 FULVESTRANT 178 70% 1% 149 Search FULVESTRANT Search FULVESTRANT
8 ENDOCRINE THERAPY 146 43% 1% 261 Search ENDOCRINE+THERAPY Search ENDOCRINE+THERAPY
9 LETROZOLE 134 42% 1% 246 Search LETROZOLE Search LETROZOLE
10 GPR30 129 69% 1% 109 Search GPR30 Search GPR30

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 ANASTROZOLE 591 65% 3% 564
2 TAMOXIFEN 587 27% 10% 1902
3 ADJUVANT TAMOXIFEN 408 59% 2% 463
4 LETROZOLE 329 51% 2% 464
5 ENDOCRINE THERAPY 329 40% 3% 646
6 ANTIESTROGENS 328 51% 2% 463
7 FIRST LINE THERAPY 320 62% 2% 328
8 ER BETA 312 42% 3% 581
9 AROMATASE INHIBITORS 279 36% 3% 634
10 TAMOXIFEN THERAPY 271 53% 2% 359

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HORMONES & CANCER 2 13% 0% 13

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer 2015 5 150 82%
Estrogen receptors: How do they signal and what are their targets 2007 547 303 50%
Mechanisms of Endocrine Resistance in Breast Cancer 2011 183 81 64%
Combinatorial control of gene expression by nuclear receptors and coregulators 2002 924 95 59%
The multifaceted mechanisms of estradiol and estrogen receptor signaling 2001 676 52 85%
Selective estrogen receptor modulators (SERMs): A review of clinical data 2015 2 46 91%
The different roles of ER subtypes in cancer biology and therapy 2011 147 176 66%
Minireview: G Protein-Coupled Estrogen Receptor-1, GPER-1: Its Mechanism of Action and Role in Female Reproductive Cancer, Renal and Vascular Physiology 2012 67 71 77%
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review 2012 66 73 78%
The G-protein-coupled estrogen receptor GPER in health and disease 2011 141 174 67%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 STEROID HORMONES SECT 65 76% 0.2% 45
2 JC HEUSON CANCEROL MAMMAIRE 27 62% 0.1% 28
3 EDINBURGH BREAST UNIT 27 38% 0.3% 57
4 RECEPTOR BIOL SECT 19 36% 0.2% 43
5 MIDLIFE HLTH 17 68% 0.1% 15
6 ALFRED G KNUDSON CHAIR CANC 17 100% 0.0% 8
7 BREAST 15 12% 0.6% 118
8 HLTH SCI IL 1 15 71% 0.1% 12
9 HORMONAL CARCINOGENESIS 14 55% 0.1% 17
10 LYNN SAGE BREAST CANC PROGRAM 12 75% 0.0% 9

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000017542 GLUCOCORTICOID RECEPTOR//GLUCOCORTICOID RESISTANCE//TRANSREPRESSION
2 0.0000013364 MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS
3 0.0000010147 2 METHOXYESTRADIOL//INDOLE 3 CARBINOL//3 3 DIINDOLYLMETHANE
4 0.0000009915 STEROIDS//OSW 1//SQUALAMINE
5 0.0000008991 ALDOSE REDUCTASE//ALDO KETO REDUCTASE//17 BETA HYDROXYSTEROID DEHYDROGENASE
6 0.0000008774 BREAST CANCER//ACCELERATED PARTIAL BREAST IRRADIATION//PARTIAL BREAST IRRADIATION
7 0.0000008239 MAMMARY GLAND//MOUSE MAMMARY TUMOR VIRUS//JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
8 0.0000008151 ALLOPREGNANOLONE//PREMATURE EJACULATION//NEUROSTEROID
9 0.0000008056 17 BETA AMINOESTROGENS//PROLAME//PENTOLAME
10 0.0000007137 ENDOMETRIUM//AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY//DECIDUA